Two of the firm's top health-care funds reject defensive strategies and invest in medical innovation over the long term. Among their picks: Becton Dickinson, Amgen, UnitedHealth, Sarepta Therapeutics, Novartis, Uniqure.
Two of the firm's top health-care funds reject defensive strategies and invest in medical innovation over the long term. Among their picks: Becton Dickinson, Amgen, UnitedHealth, Sarepta Therapeutics, Novartis, Uniqure.
Share this Article
Comment on this Article
Recommended
Please to comment